{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"LivaNova PLC"},"Symbol":{"label":"Symbol","value":"LIVN"},"Address":{"label":"Address","value":"20 EASTBOURNE TERRACE, LONDON, W2 6LG, United Kingdom"},"Phone":{"label":"Phone","value":"+44 2033250660"},"Industry":{"label":"Industry","value":"Biotechnology: Electromedical & Electrotherapeutic Apparatus"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"Europe"},"CompanyDescription":{"label":"Company Description","value":"LivaNova PLC is a global medical technology company built on nearly five decades of experience and a relentless commitment to improve the lives of patients around the world. Our advanced technologies and breakthrough treatments provide meaningful solutions for the benefit of patients healthcare professionals and healthcare systems. At LivaNova we understand the importance of bringing both clinical and economic value to our customers. We are a strong market-leading medical technology and services company offering a diverse product portfolio and global reach. LivaNova is listed on the NASDAQ stock exchange under the ticker symbol LIVN. LivaNova has approximately 3000 employees worldwide. We are headquartered in London UK and maintain a presence in more than 100 countries. LivaNova is a worldwide leader in advanced circulatory support cardiopulmonary and neuromodulation dedicated to creating meaningful products and therapies that transform lives each and every day."},"CompanyUrl":{"label":"Company Url","value":"https://www.livanova.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Badri Amurthur","title":"Chief Technology Officer"},{"name":"Matt J. Dodds","title":"Senior VP-Corporate Development & IT"},{"name":"Vladimir A. Makatsaria","title":"Chief Executive Officer & Director"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}